January 6, 2023Jeantet appoints four new partnersParis, 1st January 2023 – Jeantet announces the appointment of 4 new partners on 1st January 2023: Maxime Brotz (M&A),…Awards & appointments
December 22, 2022Jeantet advises Port Designs in connection with its acquisition of a majority interest in NoaticParis, le 22 décembre 2022 – Jeantet advised the Port Designs Group, a company specialized in IT mobility, owned by the…Key Cases & Operations
December 16, 2022Jeantet advises Turenne Santé in its acquisition of a minority stake in the capital of the Kephren GroupParis, December 16, 2022, Jeantet advised Turenne Santé in its acquisition of a minority stake in the capital of…Key Cases & Operations
September 15, 2022Jeantet advises the China Medical System Group in connection with the acquisition of a participating interest in Eye Tech CareParis, 15 September 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) the…Awards & appointments
February 15, 2022Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in PhodéParis, February 15, 2022 – Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in…Key Cases & Operations
February 2, 2022Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in H.A.C.Pharma to support the company’s development and strengthen its product portfolioParis, February 2, 2022– Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in the…Key Cases & Operations
January 14, 2022Jeantet advises Dzeta in connection with its acquisitions of majority interests in Technigrès and PORT DesignsParis, January 11, 2022 – Jeantet advised the investment company Dzeta in connection with its acquisitions of majority…Key Cases & Operations